Palvella Therapeutics (PVLA) Exchange Rate Effect (2014 - 2026)
Palvella Therapeutics' (PVLA) quarterly Exchange Rate Effect came in at -$15000.0 in Q1 2026, down 150.0% year-on-year from $30000.0 in Q1 2025, and up 97.54% on a QoQ basis from -$610000.0 in Q4 2025.
Palvella Therapeutics (PVLA) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Palvella Therapeutics (PVLA) has 13 years of Exchange Rate Effect data on file, last reported at -$15000.0 in Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 150.0% year-over-year to -$15000.0 in Q1 2026; TTM through Mar 2026 was $37000.0, a 1333.33% increase from a year earlier, with the FY2025 full-year figure at $46000.0, up 1433.33% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$15000.0, up from -$610000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for PVLA reached as high as $1.9 million in Q4 2022 and fell as low as -$3.3 million in Q2 2022.
- Historically, Exchange Rate Effect has averaged -$367214.3 across 5 years, with a median of -$45000.0 in 2023.
- Across the five-year window, Exchange Rate Effect jumped 315.39% in 2022 and sank 20433.33% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at $1.9 million in 2022, then plunged by 103.86% to -$75000.0 in 2023, then surged by 104.0% to $3000.0 in 2024, then sank by 20433.33% to -$610000.0 in 2025, then surged by 97.54% to -$15000.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$15000.0 in Q1 2026, -$610000.0 in Q4 2025, and $770000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - | -15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15,000.00 |
| Mar 31, 2026 | -15,000.00 |
| Dec 31, 2025 | -610,000.00 |
| Dec 31, 2025 | -610,000.00 |
| Sep 30, 2025 | 770,000.00 |
| Sep 30, 2025 | 770,000.00 |
| Jun 30, 2025 | -108,000.00 |
| Jun 30, 2025 | -108,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2023 | -75,000.00 |
| Dec 31, 2023 | -75,000.00 |
| Sep 30, 2023 | -337,000.00 |
| Sep 30, 2023 | -337,000.00 |
| Jun 30, 2023 | 212,000.00 |
| Jun 30, 2023 | 212,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Mar 31, 2023 | 200,000.00 |